Intratumoral Injection of mRNA-2752 and Pembrolizumab for High-Risk Ductal Carcinoma In Situ: A Phase 1 Nonrandomized Clinical Trial. Read more about Intratumoral Injection of mRNA-2752 and Pembrolizumab for High-Risk Ductal Carcinoma In Situ: A Phase 1 Nonrandomized Clinical Trial.
Molecular Testing for the World Health Organization Classification of Central Nervous System Tumors: A Review. Read more about Molecular Testing for the World Health Organization Classification of Central Nervous System Tumors: A Review.
Bilateral Mastectomy vs Lumpectomy and Breast Cancer Mortality Risk. Read more about Bilateral Mastectomy vs Lumpectomy and Breast Cancer Mortality Risk.
Efficacy of Adding Veliparib to Temozolomide for Patients With MGMT-Methylated Glioblastoma: A Randomized Clinical Trial. Read more about Efficacy of Adding Veliparib to Temozolomide for Patients With MGMT-Methylated Glioblastoma: A Randomized Clinical Trial.
Lenvatinib Plus Ifosfamide and Etoposide in Children and Young Adults With Relapsed Osteosarcoma: A Phase 2 Randomized Clinical Trial. Read more about Lenvatinib Plus Ifosfamide and Etoposide in Children and Young Adults With Relapsed Osteosarcoma: A Phase 2 Randomized Clinical Trial.
Unplanned Hospitalization Prediction During Chemoradiotherapy Via Machine Learning Classifiers-Reply. Read more about Unplanned Hospitalization Prediction During Chemoradiotherapy Via Machine Learning Classifiers-Reply.
American Radium Society Appropriate Use Criteria for Unresectable Locally Advanced Non-Small Cell Lung Cancer. Read more about American Radium Society Appropriate Use Criteria for Unresectable Locally Advanced Non-Small Cell Lung Cancer.
Machine Learning-Based Prediction of Hospitalization During Chemoradiotherapy With Daily Step Counts. Read more about Machine Learning-Based Prediction of Hospitalization During Chemoradiotherapy With Daily Step Counts.
Population Attributable Risk of Advanced-Stage Breast Cancer by Race and Ethnicity. Read more about Population Attributable Risk of Advanced-Stage Breast Cancer by Race and Ethnicity.
Systemic Anticancer Therapy and Thromboembolic Outcomes in Hospitalized Patients With Cancer and COVID-19. Read more about Systemic Anticancer Therapy and Thromboembolic Outcomes in Hospitalized Patients With Cancer and COVID-19.